Spelling suggestions: "subject:"A e aspiring""
21 |
Prevalence, profile, predictors, and natural history of aspirin resistance measured by the ultegra rapid platelet function assay-asa in patients with coronary artery diseaseCheng, Xi, January 2005 (has links)
Thesis (M. Phil.)--University of Hong Kong, 2005. / Title proper from title frame. Also available in printed format.
|
22 |
Strength and density variations of tabletsKerridge, John Charles January 1988 (has links)
No description available.
|
23 |
A meta-analysis of non-steroidal anti-inflammatory drugs and serious upper gastrointestinal bleedingLewis, Stephanie C. January 1998 (has links)
No description available.
|
24 |
Effects of antiplatelet agents on platelet and leucocyte function : from laboratory research to clinical practiceZhao, Lian January 2003 (has links)
No description available.
|
25 |
Investigation of acetylsalicylic acid bioavailability and its effect on prostaglandin-F₂α in dogsOwonubi, Mary O January 2011 (has links)
Digitized by Kansas Correctional Industries
|
26 |
A double-blind study to compare mefenamic acid with aspirin in post-surgical painCudmore, Christopher John. January 1981 (has links)
Thesis (M.S.)--University of Michigan, 1981. / Typescript (photocopy). Includes bibliographical references (leaves 95-105). Also issued in print.
|
27 |
A double-blind study to compare mefenamic acid with aspirin in post-surgical painCudmore, Christopher John. January 1981 (has links)
Thesis (M.S.)--University of Michigan, 1981. / Typescript (photocopy). eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references (leaves 95-105).
|
28 |
A study of the product resulting from the reaction of acetylsalicylic acid and morphine, acetylsalicylic acid and codeineChang, Charles Chee Kong. January 1940 (has links)
Thesis (M.S.)--University of Wisconsin--Madison, 1940. / Typescript. eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references (leaves 24-27).
|
29 |
The Effects of Aspirin and Cyclosporine on Canine Platelet Function and Cyclooxygenase ExpressionThomason, John Metcalfe 12 May 2012 (has links)
Immune-mediated hemolytic anemia (IMHA) is one of the most common causes of anemia in dogs. Despite aggressive therapy, there is a 50% mortality rate in IMHA patients, and the most common cause of death is thromboembolic disease, particularly pulmonary thromboembolism. With the high thromboembolism rate in dogs with IMHA, anti-platelet therapy with aspirin can be a life-saving preventative therapy. Along with anti-platelet therapy, immunosuppressive therapy is needed to decrease erythrocyte destruction. Cyclosporine has become a popular medication for immunosuppression in IMHA patients. Unfortunately, recent human reports have suggested that cyclosporine could activate platelets and contribute to a hypercoagulable state. With the goal of improving therapy, these studies investigated the role aspirin plays in inhibiting platelet function and cyclooxygenase expression, an enzyme that enhances platelet reactivity. The effect of cyclosporine on platelet reactivity and hypercoagulablity was investigated to determine if this medication would create activated platelets and a prothrombotic state.
|
30 |
Teratogenic effects on the CD-1 mouse embryo exposed to concurrent doses of ethanol and aspirin /Guy, Julia F. January 1986 (has links)
No description available.
|
Page generated in 0.0597 seconds